| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.40B | 106.18B | 99.00B | 96.37B | 88.06B | 83.78B |
| Gross Profit | 5.77B | 13.10B | 10.51B | 6.91B | 5.39B | 7.39B |
| EBITDA | 4.02B | 9.41B | 7.29B | 4.32B | 2.83B | 4.50B |
| Net Income | 2.70B | 6.41B | 4.70B | 2.94B | 1.71B | 2.98B |
Balance Sheet | ||||||
| Total Assets | 67.60B | 74.44B | 67.60B | 63.92B | 55.71B | 57.62B |
| Cash, Cash Equivalents and Short-Term Investments | 19.96B | 14.68B | 19.96B | 13.02B | 11.65B | 11.66B |
| Total Debt | 6.79B | 6.13B | 6.79B | 5.72B | 5.79B | 5.90B |
| Total Liabilities | 33.51B | 34.41B | 33.51B | 33.84B | 28.19B | 30.82B |
| Stockholders Equity | 34.09B | 40.02B | 34.09B | 30.08B | 27.53B | 26.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.76B | 8.11B | 1.80B | 1.23B | 650.00M |
| Operating Cash Flow | 0.00 | -3.23B | 8.14B | 1.88B | 1.28B | 757.00M |
| Investing Cash Flow | 0.00 | -271.00M | -1.35B | 417.00M | -116.00M | -136.00M |
| Financing Cash Flow | 0.00 | -1.72B | 75.00M | -929.00M | -1.16B | -799.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥33.71B | 8.76 | ― | 3.86% | 18.56% | 86.25% | |
71 Outperform | ¥36.77B | 5.76 | ― | 3.01% | 7.25% | 36.43% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥41.75B | 7.74 | ― | 6.02% | -5.07% | -26.79% | |
62 Neutral | ¥2.84T | 7.65 | 11.39% | 2.93% | 2.61% | 10.15% | |
58 Neutral | ¥121.60B | 20.27 | 4.48% | 3.30% | 3.93% | 16.91% | |
56 Neutral | ¥55.61B | 11.83 | 6.98% | 7.35% | 9.08% | -42.76% |